KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy

Published:2021-12 Issue:12 Volume:16 Page:2065-2077
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Scalera Stefano,Mazzotta Marco,Corleone Giacomo,Sperati Francesca,Terrenato Irene,Krasniqi Eriseld,Pizzuti Laura,Barba Maddalena,Vici Patrizia,Gallo Enzo,Buglioni Simonetta,Visca Paolo,Pescarmona Edoardo,Marinelli Daniele,De Nicola Francesca,Ciuffreda Ludovica,Goeman Frauke,Fanciulli Maurizio,Giusti Raffaele,Vecchione Andrea,De Maria Ruggero,Cappuzzo Federico,Marchetti Paolo,Ciliberto Gennaro,Maugeri-Saccà Marcello

Funder

Roche

Ministry of Health -Singapore

Pfizer

Ministero della Salute

Eisai

Associazione Italiana per la Ricerca sul Cancro

Novartis

Airc Italian Foundation for Cancer Research

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. NRF2 in human neoplasm: cancer biology and potential therapeutic target;Liu;Pharmacol Ther,2021

2. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer;Kansanen;Redox Biol,2013

3. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases;Cuadrado;Nat Rev Drug Discov,2019

4. NRF2 and the hallmarks of cancer;Rojo de la Vega;Cancer Cell,2018

5. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma;Radiotherapy and Oncology;2024-06

2. Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC;Journal of Thoracic Oncology;2024-06

3. Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities;Trends in Pharmacological Sciences;2024-06

4. TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations;Frontiers in Oncology;2024-04-22

5. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma;International Journal of Biological Macromolecules;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3